Finch Therapeutics Group, Inc. (FNCH)
OTCMKTS
· Delayed Price · Currency is USD
13.17
+0.17 (1.31%)
May 13, 2025, 3:56 PM EDT
Finch Therapeutics Group Market Cap
Finch Therapeutics Group has a market cap or net worth of $21.15 million as of May 14, 2025. Its market cap has increased by 355.06% in one year.
Market Cap
21.15M
Enterprise Value
34.10M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$13.17
Market Cap Chart
Since March 19, 2021, Finch Therapeutics Group's market cap has decreased from 1.01B to 21.15M, a decrease of -97.90%. That is a compound annual growth rate of -60.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2025 | 21.15M | 16.55% |
| Dec 31, 2024 | 18.15M | 213.02% |
| Dec 29, 2023 | 5.80M | -74.79% |
| Dec 30, 2022 | 22.99M | -95.14% |
| Dec 31, 2021 | 473.36M | -52.91% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo Inc. | 1.64B |
| Nika Pharmaceuticals | 1.02B |
| Veradigm | 729.62M |
| Tian'an Technology Group | 591.73M |
| CytoDyn | 497.14M |
| Glass House Brands | 478.11M |
| Elite Pharmaceuticals | 468.54M |
| Northwest Biotherapeutics | 395.18M |